SB325,10,1311
e.
121-[(tetrahydropyran-4-yl)methyl]-3-(2,2,3,3-tetramethylcyclopropoyl)indole,
13commonly known as A-834,735;
SB325,10,2114
9. Any compound structurally derived from
15N-adamantyl-1H-indole-3-carboxamide by substitution at the nitrogen atom of
16the indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
17cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
181-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
19(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the
20indole ring to any extent, whether or not substituted in the adamantyl ring to any
21extent. Substances specified under this subdivision include:
SB325,10,2322
a. N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide, commonly known
23as 2NE1;
SB325,10,2524
b. N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide,
25commonly known as STS-135;
SB325,11,8
110. Any compound structurally derived from
2N-adamantyl-1H-indazole-3-carboxamide by substitution at either nitrogen atom
3of the indazole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
4cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
51-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
6(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the
7indazole ring to any extent, whether or not substituted in the adamantyl ring to any
8extent. Substances specified under this subdivision include:
SB325,11,109
a. 1-pentyl-N-(1-adamantyl)-1H-indazole-3-carboxamide, commonly
10known as AKB48;
SB325,11,1211
b.
1-(5-fluoropentyl)-N-(1-adamantyl)-1H-indazole-3-carboxamide,
12commonly known as 5F-AKB48.
SB325,11,2013
11. Any compound structurally derived from
14N-naphthyl-1H-indazole-3-carboxamide by substitution at either nitrogen atom
15of the indazole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
16cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
171-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
18(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the
19indazole ring to any extent, whether or not substituted in the naphthyl ring to any
20extent.
SB325,11,2221
12. [1,1'-biphenyl]-3-yl-carbamic acid, cyclohexyl ester, commonly known as
22URB-602;
SB325,12,223
13.
24[(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,
16a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate, commonly known as CP
250,556-1;
SB325,12,53
14.
4(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,1
50a-tetrahydrobenzo[c]chromen-1-ol, commonly known as HU-210;
SB325,12,86
15.
7(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10
8a-tetrahydrobenzo[c]chromen-1-ol, commonly known as HU-211;
SB325,12,119
16.
103-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pe
11ntyl-2,5-cyclohexadiene-1,4-dione, commonly known as HU-331;
SB325,12,1412
17.
13((6aR,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo
14[c]chromen-9-yl)methanol, commonly known as JWH-051;
SB325,12,1615
18. (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro
16-6,6,9-trimethyl-6H-dibenzo[b,d]pyran, commonly known as JWH-133;
SB325,12,1917
19.
18(6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-[(2R)-1,1,2-trimethylbutyl]-6a,7,10,1
190a-tetrahydrobenzo[c]chromene, commonly known as JWH-359;
SB325,12,2120
20. Napthalen-1-yl-(4-pentyloxynapthalen-1-yl)methanone, commonly
21known as CB-13;
SB325,12,2322
21. N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecamide,
23commonly known as CB-25;
SB325,12,2524
22. N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecamide, commonly
25known as CB-52;
SB325,13,3
123.
2N-(benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroqui
3noline-3-carboxamide, commonly known as JTE-907;
SB325,13,64
24.
5N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethy
6lcyclopropane-1-carboxamide, commonly known as A-836,339;
SB325,13,97
25.
8Anthracen-9-yl{2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methano
9ne, commonly known as WIN 56,098;
SB325,13,1110
26. 6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one,
11commonly known as URB-754;
SB325,13,1312
27. [3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate, commonly
13known as URB-597;
SB325,13,1614
28.
15(-)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluorobutyl-1-sulfon
16ate, commonly known as BAY 38-7271.
SB325,13,2417
29. Any compound structurally derived from 1H-indole-3-carboxylic acid
18quinolinyl ester by substitution at the nitrogen atom of the indole ring by alkyl,
19haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
201-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
211-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
22(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the
23indole ring to any extent, whether or not substituted in the quinoline ring to any
24extent. Substances specified under this subdivision include:
SB325,14,2
1a. 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester, commonly known
2as PB-22;
SB325,14,43
b. 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester,
4commonly known as 5F-PB-22;
SB325,14,65
c. 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester,
6commonly known as BB-22.
SB325,14,147
30. Any compound structurally derived from
8N-naphthyl-1H-indole-3-carboxamide by substitution at the nitrogen atom of the
9indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
10cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
111-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
12(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the
13indole ring to any extent, whether or not substituted in the naphthyl ring to any
14extent. Substances specified under this subdivision include:
SB325,14,1615
a. 1-pentyl-N-(1-naphthyl)-1H-indole-3-carboxamide, commonly known as
16NNEI or MN-24;
SB325,14,1817
b. 1-(5-fluoropentyl)-N-(1-naphthyl)-1H-indole-3-carboxamide, commonly
18known as 5F-NNEI or 5F-MN-24.
SB325,15,219
31. Any compound structurally derived from 3-(pyridinoyl)indole by
20substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl,
21alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
222-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl,
231-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group,
24whether or not further substituted in the indole ring to any extent, whether or not
1substituted in the pyridine ring to any extent. Substances specified under this
2subdivision include:
SB325,15,33
a. 1-pentyl-3-(3-pyridinoyl)indole;
SB325,15,44
b. 1-(5-fluoropentyl)-3-(3-pyridinoyl)indole.
SB325,7
5Section
7. 961.14 (4) (te), (th), (tL), (tp), (tr), (tu) and (ty) of the statutes are
6repealed.
SB325,8
7Section
8. 961.14 (4) (uv) of the statutes is created to read:
SB325,15,98
961.14
(4) (uv) 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone,
9commonly known as methoxetamine.
SB325,9
10Section
9. 961.14 (4) (wa) of the statutes is created to read:
SB325,15,1211
961.14
(4) (wa) 4-iodo-2,5-dimethoxyamphetamine, commonly known as
12DOI.
SB325,10
13Section
10. 961.14 (4) (wb) of the statutes is created to read:
SB325,15,1514
961.14
(4) (wb) 4-chloro-2,5-dimethoxyamphetamine, commonly known as
15DOC.
SB325,11
16Section
11. 961.14 (4) (wk) of the statutes is created to read:
SB325,15,1817
961.14
(4) (wk) 2,5-dimethoxy-4-ethylphenethylamine, commonly known as
182C-E.
SB325,12
19Section
12. 961.14 (4) (wL) of the statutes is created to read:
SB325,15,2120
961.14
(4) (wL) 2,5-dimethoxy-4-methylphenethylamine, commonly known
21as 2C-D.
SB325,13
22Section
13. 961.14 (4) (wm) of the statutes is created to read:
SB325,15,2423
961.14
(4) (wm) 2,5-dimethoxy-4-chlorophenethylamine, commonly known
24as 2C-C.
SB325,14
25Section
14. 961.14 (4) (wn) of the statutes is created to read:
SB325,16,2
1961.14
(4) (wn) 2,5-dimethoxy-4-ethylthiophenethylamine, commonly known
2as 2C-T-2.
SB325,15
3Section
15. 961.14 (4) (wo) of the statutes is created to read:
SB325,16,54
961.14
(4) (wo) 2,5-dimethoxy-4-isopropylthiophenethylamine, commonly
5known as 2C-T-4.
SB325,16
6Section
16. 961.14 (4) (wp) of the statutes is created to read:
SB325,16,77
961.14
(4) (wp) 2,5-dimethoxyphenethylamine, commonly known as 2C-H.
SB325,17
8Section
17. 961.14 (4) (wq) of the statutes is created to read:
SB325,16,109
961.14
(4) (wq) 2,5-dimethoxy-4-nitrophenethylamine, commonly known as
102C-N.
SB325,18
11Section
18. 961.14 (4) (wr) of the statutes is created to read:
SB325,16,1312
961.14
(4) (wr) 2,5-dimethoxy-4-(n)-propylphenethylamine, commonly
13known as 2C-P.
SB325,19
14Section
19. 961.14 (4) (ws) of the statutes is created to read:
SB325,16,1915
961.14
(4) (ws) Any compound structurally derived from
16N-benzyl-2-(2,5-dimethoxyphenyl)ethanamine by substitution at the nitrogen
17atom, or on either ring, with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, halide
18or nitro substituents, or by any combination of these modifications. Substances
19specified under this paragraph include:
SB325,16,2220
1.
212-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine,
22commonly known as 25I-NBOMe.
SB325,16,2523
2.
242-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine,
25commonly known as 25C-NBOMe.
SB325,17,3
13.
22-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine,
3commonly known as 25B-NBOMe.
SB325,17,54
4. 2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,
5commonly known as 25E-NBOMe.
SB325,20
6Section
20. 961.14 (4) (wv) of the statutes is created to read:
SB325,17,87
961.14
(4) (wv) N,N-diallyl-5-methoxytryptamine, commonly known as
85-MeO-DALT.
SB325,21
9Section
21. 961.14 (4) (ww) of the statutes is created to read:
SB325,17,1010
961.14
(4) (ww) 5-(2-aminopropyl)benzofuran, commonly known as 5-APB.
SB325,22
11Section
22. 961.14 (4) (wx) of the statutes is created to read:
SB325,17,1212
961.14
(4) (wx) 6-(2-aminopropyl)benzofuran, commonly known as 6-APB.
SB325,23
13Section
23. 961.14 (4) (wy) of the statutes is created to read:
SB325,17,1514
961.14
(4) (wy) 5-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known
15as 5-APDB.
SB325,24
16Section
24. 961.14 (4) (wz) of the statutes is created to read:
SB325,17,1817
961.14
(4) (wz) 6-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known
18as 6-APDB.
SB325,25
19Section
25. 961.14 (4) (xa) of the statutes is created to read:
SB325,17,2020
961.14
(4) (xa) 5-iodo-2-aminoindane, commonly known as 5-IAI.
SB325,26
21Section
26. 961.14 (4) (xb) of the statutes is created to read:
SB325,17,2222
961.14
(4) (xb) 4-methoxymethamphetamine, commonly known as PMMA.
SB325,27
23Section
27. 961.14 (7) (intro.) of the statutes is amended to read:
SB325,18,324
961.14
(7) Stimulants. (intro.) Any material, compound, mixture or
25preparation which contains any quantity of any of the following substances having
1a stimulant effect on the central nervous system, including any of their
precursors,
2analogs, salts, isomers and salts of isomers that are theoretically possible within the
3specific chemical designation:
SB325,28
4Section
28. 961.14 (7) (L) of the statutes is repealed and recreated to read:
SB325,18,165
961.14
(7) (L)
Substituted cathinones. Any compound, except bupropion or
6compounds scheduled elsewhere in this chapter, that is structurally derived from
72-amino-propan-1-one by substitution at the 1-position with either phenyl,
8napthyl, or thiophene ring systems, whether or not the compound is further modified
9in any of the following ways: by substitution in the ring system to any extent with
10alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, or halide substituents, whether or
11not further substituted in the ring system by one or more other univalent
12substituents; by substitution at the 3-position with an acyclic alkyl substituent; by
13substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or
14methoxybenzyl groups; by inclusion of the 2-amino nitrogen atom in a cyclic
15structure; or by any combination of these modifications. Substances specified under
16this subdivision include:
SB325,18,1717
1. Methcathinone.
SB325,18,1818
2. Methylenedioxypyrovalerone, commonly known as MDPV.
SB325,18,1919
3. 4-methylmethcathinone, commonly known as mephedrone or 4-MMC.
SB325,18,2020
4. 4-methylethcathinone, commonly known as 4-MEC.
SB325,18,2121
5. 4-methoxy-alpha-pyrrolidinopropiophenone, commonly known as MOPPP.
SB325,18,2322
6. 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone, commonly known
23as MDPPP.
SB325,18,2424
7. Alpha-pyrrolidinovalerophenone, commonly known as alpha-PVP.